Overview

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

Status:
Recruiting
Trial end date:
2021-11-26
Target enrollment:
Participant gender:
Summary
The investigators would like to study the genetic and molecular outcomes that results after a short term neoadjuvant hormonal therapy on patients with breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Agendia
Treatments:
Exemestane
Letrozole
Tamoxifen